Table 2.
Characteristics of patients, deprivation quintiles, and fluoroquinolone claim rates
| Characteristics | |
|---|---|
| Patients | Median (IQR) |
| Total beneficiaries per provider | 332 (198–526) |
| Average beneficiary age (years) | 72.7 (71.0–74.2) |
| % Female beneficiaries per provider | 58.9 (53.4–64.8) |
| % White beneficiaries per provider | 69.8 (44.9–82.6) |
| % Black beneficiaries per provider | 10.4 (5.5–18.9) |
| % Hispanic beneficiaries per provider | 15.0 (7.9–38.6) |
| % Other ethnicities per provider | 6.4 (0–11.6) |
| % Beneficiaries with dual insurance | 22.7 (12.2–37.7) |
| Risk score | 1.4 (1.1–1.9) |
| SDI a | n (%) |
| Providers in quintile 1 -SDI [85,100] (most deprived) | 2337 (19.5) |
| Providers in quintile 2 -SDI [71, 85) | 2374 (19.8) |
| Providers in quintile 3 -SDI [48, 71) | 2417 (20.1) |
| Providers in quintile 4 -SDI [29, 48) | 2367 (19.7) |
| Providers in quintile 5 -SDI [1, 29) (least deprived) | 2501 (20.8) |
| Claim Rates | Median (IQR) |
| Ciprofloxacin claims per provider | 16 (0–28) |
| Levofloxacin claims per provider | 0 (0–16) |
| Moxifloxacin claims per provider | 0 (0–0) |
| Ofloxacin claims per provider | 0 (0–0) |
| Total fluoroquinolone claims per providerb | 24 (15–47) |
| Rate of claims/ 1000 beneficiaries per provider | 88.8 (53.5–154.6) |
Note. IQR, Interquartile Range; SDI, Social Deprivation Index.
a
Providers were grouped into SDI quintiles.
b
Fluoroquinolone claims included ciprofloxacin, levofloxacin, moxifloxacin, ofloxacin.